Infliximab treatment induces levels of the active azathioprine metabolite TGTP in Crohn's disease

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):E54-5. doi: 10.1002/ibd.22998.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Apoptosis / drug effects
  • Azathioprine / therapeutic use*
  • Crohn Disease / drug therapy*
  • Drug Therapy, Combination
  • Gastrointestinal Agents / therapeutic use*
  • Guanosine Triphosphate / analogs & derivatives*
  • Guanosine Triphosphate / metabolism
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infliximab
  • Prognosis
  • Thionucleotides / metabolism*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Immunosuppressive Agents
  • Thionucleotides
  • Tumor Necrosis Factor-alpha
  • 6-thioguanosine 5'-triphosphate
  • Guanosine Triphosphate
  • Infliximab
  • Azathioprine